These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38308915)

  • 21. Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey.
    Ziemssen T; Giovannoni G; Alvarez E; Bhan V; Hersh C; Hoffmann O; Oreja-Guevara C; Robles-Cedeño RR; Trojano M; Vermersch P; Dobay P; Khwaja M; Stadler B; Rauser B; Hach T; Piani-Meier D; Burton J
    J Med Internet Res; 2021 Oct; 23(10):e29558. PubMed ID: 34612826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of the patient's perspective in decision-making in multiple sclerosis: Results of the OwnMS patient perspectives study.
    Florio-Smith J; Ayer M; Colhoun S; Daykin N; Hamill B; Liu X; Rogers E; Thomson A; Balzan RP
    Mult Scler Relat Disord; 2023 Jul; 75():104757. PubMed ID: 37210990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk knowledge of people with relapsing-remitting multiple sclerosis - Results of an international survey.
    Giordano A; Liethmann K; Köpke S; Poettgen J; Rahn AC; Drulovic J; Beckmann Y; Sastre-Garriga J; Galea I; Heerings M; Jongen PJ; Vettorazzi E; Solari A; Heesen C;
    PLoS One; 2018; 13(11):e0208004. PubMed ID: 30496233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The multiple sclerosis rating scale, revised (MSRS-R): development, refinement, and psychometric validation using an online community.
    Wicks P; Vaughan TE; Massagli MP
    Health Qual Life Outcomes; 2012 Jun; 10():70. PubMed ID: 22709981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The validity, responsiveness, and score interpretation of the PROMISnq Physical Function - Multiple Sclerosis 15a short form in multiple sclerosis.
    Kamudoni P; Amtmann D; Johns J; Cook KF; Salem R; Salek S; Raab J; Middleton R; Repovic P; Alschuler KN; von Geldern G; Wundes A; Barrett A; Olayinka-Amao O; Henke C
    Mult Scler Relat Disord; 2022 Jun; 62():103753. PubMed ID: 35598408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients' experiences of self-identification, seeking support, and anticipation of potential relapse in multiple sclerosis.
    Wicks CR; Sloan R; DiMauro S; Thompson EL; Billington S; Webb M; Pepper G
    Mult Scler Relat Disord; 2021 Nov; 56():103259. PubMed ID: 34628265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applying the theory of planned behaviour to multiple sclerosis patients' decisions on disease modifying therapy--questionnaire concept and validation.
    Kasper J; Köpke S; Fischer K; Schäffler N; Backhus I; Solari A; Heesen C
    BMC Med Inform Decis Mak; 2012 Jul; 12():60. PubMed ID: 22747904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Motherhood choice in multiple sclerosis (MoMS) development and piloting of patient-reported outcome measures.
    Steinberg L; Peper J; Köpke S; Solari A; Giordano A; Gold SM; Hellwig K; Heesen C; Rahn AC
    Mult Scler Relat Disord; 2022 Jul; 63():103831. PubMed ID: 35504172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-assessment of people with relapsing-remitting and progressive multiple sclerosis towards burden of disease, progression, and treatment utilization-Results of a large-scale cross-sectional online survey (MS Perspectives).
    Bayas A; Schuh K; Christ M
    Mult Scler Relat Disord; 2022 Dec; 68():104166. PubMed ID: 36115289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the French version of the Multiple Sclerosis Intimacy And Sexuality Questionnaire-19: A preliminary study.
    Devis M; Stoquart G; Géonet M; London F; van Pesch V
    Mult Scler Relat Disord; 2022 Sep; 65():103986. PubMed ID: 35785600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating the disutility of relapse in relapsing-remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: implications for health economic evaluation models.
    Ahmad H; Campbell JA; van der Mei I; Taylor BV; Xia Q; Zhao T; Palmer AJ
    Qual Life Res; 2023 Dec; 32(12):3373-3387. PubMed ID: 37522942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Teriflunomide for multiple sclerosis.
    He D; Zhang C; Zhao X; Zhang Y; Dai Q; Li Y; Chu L
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009882. PubMed ID: 27003123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Misconceptions about multiple sclerosis and pregnancy in the Qassim region in 2021-2022: a cross-sectional study.
    Alharbi M; Alatni R; Almuhaisni R; Albattah G; Alsaif M; Alhumidan R; Bennasser T
    Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3363-3371. PubMed ID: 37140286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and evaluation of a website with patients experiences of multiple sclerosis: a mixed methods study.
    Sippel A; Scheiderbauer J; Eklund D; Arnade S; Schmidt S; Kleiter I; Morrison R; Kofahl C; Heesen C
    BMC Neurol; 2022 Apr; 22(1):146. PubMed ID: 35443631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient- versus physician-reported relapses in multiple sclerosis: insights from a large observational study.
    Schriefer D; Haase R; Ettle B; Ziemssen T
    Eur J Neurol; 2020 Dec; 27(12):2531-2538. PubMed ID: 32643851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relapse recovery in relapsing-remitting multiple sclerosis: An analysis of the CombiRx dataset.
    Koch MW; Moral E; Brieva L; Mostert J; Strijbis EM; Comtois J; Repovic P; Bowen JD; Wolinsky JS; Lublin FD; Cutter G
    Mult Scler; 2023 Dec; 29(14):1776-1785. PubMed ID: 37830451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [French validation of the Multiple Sclerosis International Quality of Life Questionnaire].
    Baumstarck-Barrau K; Pelletier J; Simeoni MC; Auquier P;
    Rev Neurol (Paris); 2011; 167(6-7):511-21. PubMed ID: 21420136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Multiple Sclerosis Knowledge Questionnaire: a self-administered instrument for recently diagnosed patients.
    Giordano A; Uccelli MM; Pucci E; Martinelli V; Borreani C; Lugaresi A; Trojano M; Granella F; Confalonieri P; Radice D; Solari A;
    Mult Scler; 2010 Jan; 16(1):100-11. PubMed ID: 19995834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome.
    Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ
    Health Technol Assess; 2004 Mar; 8(9):iii, 1-48. PubMed ID: 14982653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma exchange in severe acute relapses of multiple sclerosis - Results from a Portuguese cohort.
    Correia I; Ribeiro JJ; Isidoro L; Batista S; Nunes C; Macário C; Borges C; Tomaz J; Sousa L
    Mult Scler Relat Disord; 2018 Jan; 19():148-152. PubMed ID: 29241141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.